Filing Details

Accession Number:
0001209191-17-048783
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-14 17:01:55
Reporting Period:
2017-08-14
Filing Date:
2017-08-14
Accepted Time:
2017-08-14 17:01:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1539029 Clearside Biomedical Inc. CLSD Pharmaceutical Preparations (2834) 452437375
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664690 A. Charles Deignan C/O Clearside Biomedical, Inc.
900 North Point Parkway, Suite 200
Alpharetta GA 30005
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-14 1,000 $7.07 65,309 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $7.05 to $7.08, inclusive. The price reported in Column 4 is a weightedaverage price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer fullinformation regarding the number of shares and prices at which the transactions were effected.